Back to All Events

Vaccines and Related Biological Products Advisory Committee (VRBPAC)

  • IQVIA Solutions Denmark A/S Denmark (map)

The US FDA has scheduled an Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting for Thursday, September 22, 2022 to discuss a Biologics License Application (BLA - 125739) for Rebyota (Fecal Microbiota, Live), with a requested indication to reduce the recurrence of Clostridioides difficile infection (CDI) in adults following antibiotic treatment for recurrent CDI infection.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-september-22-2022-meeting-announcement
Earlier Event: September 7
Peripheral and Central Nervous System Drugs Advisory Committee
Later Event: September 22
Oncologic Drug Advisory Committee